Logo do repositório

Organizing pneumonia and COVID-19

dc.contributor.authorTonon, Carolina Rodrigues [UNESP]
dc.contributor.authorTanni, Suzana Erico [UNESP]
dc.contributor.authorRocha, Juliana [UNESP]
dc.contributor.authorGodoy, Irma [UNESP]
dc.contributor.authorPolegato, Bertha Furlan [UNESP]
dc.contributor.authorPereira, Filipe Welson Leal [UNESP]
dc.contributor.authorMartins, Danilo [UNESP]
dc.contributor.authorPrudente, Robson Aparecido [UNESP]
dc.contributor.authorFranco, Estefania Thome [UNESP]
dc.contributor.authorBrizola, Fernando [UNESP]
dc.contributor.authorBaldi, Bruno Guedes
dc.contributor.authorOkoshi, Marina Politi [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.date.accessioned2025-04-29T18:56:46Z
dc.date.issued2023-12-01
dc.description.abstractOrganizing pneumonia (OP) is an interstitial lung disease, and can be cryptogenic, if no cause is identified, or secondary to several conditions. COVID-19-induced persistent inflammation can be associated with interstitial lung disease. We present a review of literature of OP and COVID-19-induced OP with an illustrative case. A 38-year-old man was admitted with COVID-19 that required mechanical ventilation for 56 days. Initial chest computed tomography (CT) revealed diffuse bilateral ground-glass opacities in the lungs with consolidation areas involving 75 % of the parenchyma. After weaning from MV, the patient still required oxygen supplementation. A new chest CT scan also showed extensive diffuse areas of consolidation and ground-glass opacity. OP was hypothesized and 40 mg/day prednisone initiated and continued for six months with resolution of lung functional and image abnormalities. Organizing pneumonia should be included in the differential diagnosis of COVID-19 patients with respiratory symptoms after partial pulmonary recovery.en
dc.description.affiliationInternal Medicine Department Botucatu Medical School Sao Paulo State University, UNESP
dc.description.affiliationPneumology Division Heart Institute (InCor) Faculty of Medicine University of Sao Paulo
dc.description.affiliationUnespInternal Medicine Department Botucatu Medical School Sao Paulo State University, UNESP
dc.format.extent458-463
dc.identifierhttp://dx.doi.org/10.1016/j.amjms.2023.09.023
dc.identifier.citationAmerican Journal of the Medical Sciences, v. 366, n. 6, p. 458-463, 2023.
dc.identifier.doi10.1016/j.amjms.2023.09.023
dc.identifier.issn1538-2990
dc.identifier.issn0002-9629
dc.identifier.scopus2-s2.0-85173216083
dc.identifier.urihttps://hdl.handle.net/11449/300945
dc.language.isoeng
dc.relation.ispartofAmerican Journal of the Medical Sciences
dc.sourceScopus
dc.titleOrganizing pneumonia and COVID-19en
dc.typeResenhapt
dspace.entity.typePublication
relation.isOrgUnitOfPublicationa3cdb24b-db92-40d9-b3af-2eacecf9f2ba
relation.isOrgUnitOfPublication.latestForDiscoverya3cdb24b-db92-40d9-b3af-2eacecf9f2ba
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatupt

Arquivos